$VABK

Virginia National Bankshares Corp (VABK): ANNOUNCES 2026 SECOND QUARTER EARNINGS

Virginia National Bankshares Corp (VABK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 vabk-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE INVESTOR RELATIONS CONTACT: Cathy W. Liles (434) 817-8267 VIRGINIA NATIONAL BANKSHARES CORPORATION ANNOUNCES 2026 SECOND QUARTER EARNINGS AND QUARTERLY DIVIDEND Charlottesville, VA – July 23, 2026 - Virg

Original reporting
Published Jul 23, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 23, 2026, 8:34 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$VABK
Bullish
medium confidence
Mentioned
$VABK
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$VABKBullishMed
01

Why it matters

Net income rose to $9.0M ($1.65 diluted EPS) versus $4.2M ($0.78) a year ago, attributed to lower cost of funds (13 bps), reduced non-interest expense, and a gain from the sale of a Bearing Insurance Group limited partnership interest. The Board declared a $0.36 per share quarterly cash dividend payable Aug 28, 2026.

02

Market read

Traders can reassess near-term valuation support from the dividend and earnings drivers, while separating recurring core performance from transaction-related gains.

03

What to watch

Deposits declined $22.5M from Dec 31, 2025, and loan balances were down 0.6% YoY, which could constrain net interest income growth if the balance sheet does not re-accelerate.

Relevance 7/10Novelty 8/10Timing: after-hours today, following the 8-K earnings release and dividend declaration

Background

This is an SEC Form 8-K (Item 2.02) with Exhibit 99.1 announcing Virginia National Bankshares’ 2026 second-quarter results and a quarterly dividend.

Company-level read

Ticker impact

$VABKBullishMedium confidence
Context

Virginia National Bankshares reported 2026 Q2 net income of $9.0M, up from $4.2M a year ago, and declared a $0.36 quarterly dividend.

Expected impact

Moderately positive near-term reaction, with follow-through tied to whether investors view the Bearing gain as recurring versus one-time.

Evidence & confidence

The filing provides specific quarterly earnings, per-share results, and dividend terms, plus drivers (13 bps cost of funds reduction, reduced expenses, and a $4.7M Bearing gain). That combination typically moves small-cap bank sentiment, though the transaction gain may temper expectations for future quarters.

Market effects

Provides a read-through on small-bank profitability drivers, especially cost of funds compression and expense efficiency.

May influence sentiment toward community banks in Virginia and nearby markets, though the filing is company-specific.

Limited global relevance; primarily affects US regional banking sentiment.

Counterpoint

The earnings upside is partly driven by a gain from the Bearing transaction, which may not repeat, so forward earnings power could be less strong than the headline suggests.

Key entities

  • Virginia National Bankshares Corporation

    NASDAQ-listed community bank reporting 2026 Q2 results and declaring a quarterly dividend.

  • Bearing Insurance Group, LLC

    Limited investment partnership interest sale generated a gain cited as a key driver of noninterest income.

  • Board of Directors

    Declared the quarterly cash dividend of $0.36 per share.

Related articles

$VABKMed

Virginia National Bankshares Corp (VABK): ANNOUNCES 2026 THIRD QUARTER EARNINGS

Virginia National Bankshares Corp (VABK) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE INVESTOR RELATIONS CONTACT: Cathy W. Liles (434) 817-8267 VIRGINIA NATIONAL BANKSHARES CORPORATION ANNOUNCES 2026 THIRD QUARTER EARNINGS Charlottesville, VA – October 29, 2026 - Virginia National Bankshares Corporation (NASDAQ: VABK) (the “Compa

$VABKMedAI 8/10

VIRGINIA NATIONAL BANKSHARES CORPORATION ANNOUNCES 2026 SECOND QUARTER EARNINGS AND QUARTERLY DIVIDEND

Virginia National Bankshares (NASDAQ: VABK) reported Q2 2026 net income of $9.0 million, or $1.65 per diluted share, versus $4.2 million, or $0.78, in Q2 2025. Results improved on lower cost of funds, reduced noninterest expense, and a gain from selling a Bearing Insurance Group interest. The board declared a $0.36 quarterly dividend (annualized yield ~3.20%).

$AMMed

Antero Midstream Corp (AM) (Q3 2026) Earnings Call Highlights: Record Volumes, Debt

Antero Midstream Corp (AM) reported Q3 2026 adjusted EBITDA of $291M, up 3% YoY. CEO Michael Kennedy expects double-digit EBITDA growth in 2027, driven by throughput growth and project completions. CFO Justin Agnew highlighted debt reduction and leverage below the 3x target. The company is pursuing new pipeline projects, including a $200M-$300M East Side Express project, with a final investment decision on a North-South pipeline expected in 2027.

$ALRSMed

Alerus Financial Corp (ALRS) Q3 2026 Earnings Call Highlights: Record Revenue and Strong

Alerus Financial Corp (ALRS) reported Q3 2026 earnings, highlighting record revenue and strong loan growth. CFO Al Villan expects $13M in purchase accounting accretion for 2026, decreasing to $9M in 2027. Chief Banking Officer Jim Collins noted strong pipelines for Q4, with significant full-relationship wins. The spot margin is expected to be down slightly. The company anticipates steady retirement and wealth revenue, and plans to raise deposit rates slowly to protect margins.

$EHCMedAI 9/10

Encompass Health Corp (EHC) (Q3 2026) Earnings Call Highlights: Raised Guidance, Strong

Encompass Health Corp (EHC) raised its 2026 guidance, reporting Q3 revenue growth of 8.9%, adjusted EBITDA up 15.5%, and adjusted EPS up 23.6%. The company expanded capacity with new hospitals and beds, while noting challenges like bad debt and regulatory uncertainty. Management expects strong performance in 2027, with continued capacity additions and managed care pricing improvements.